NMR Study of the Interaction of Beta-Blockers with Sonicated Dimyristoylphosphatidylcholine Liposomes in the Presence of Praseodymium Cation

References

• Bangham A. D., Standish M. M., Watkins J. C. Diffusion of univalent ions across the lamellae of swollen phospholipids. J. Mol. Biol. 1965; 13: 238–252
   PubMed Web of Science ®Google Scholar
• Bergelson L. D. Paramagnetic metal complexes with phospholipids and their use for studying molecular organization of membranes using the NMR method. Methods Membrane Biol. 1978; 9: 275–335
   Google Scholar
• Betageri G. V., Rogers J. A. Thermodynamics of partitioning of β–blockers in the n–octanol–buffer and liposome systems. Int. J. Pharm. 1987; 36: 165–173
   Web of Science ®Google Scholar
• Bystrov V. F., Dubrovina N. I., Barsukov L. I., Bergelson L. D. NMR differentiation of the internal and external phospholipid membrane surfaces using paramagnetic Mn2+ and Eu3+ ions. Chem. Phys. Lipids 1971; 6: 343–350
   Web of Science ®Google Scholar
• Bystrov V. F., Shapiro Yu. E., Viktorov A. V., Barsukov L. I., Bergelson L. D. 31P–NMR signals from inner and outer surfaces of phospholipid membranes. FEBS Lett. 1972; 25: 337–338
   Google Scholar
• Chapman D., Penkett S. A. Nuclear magnetic resonance spectroscopic studies of the interaction of phospholipids with cholesterol. Nature 1966; 211: 1304–1305
   PubMed Web of Science ®Google Scholar
• Cruickshank J. M. The clinical importance of cardioselectivity and lipophilicity in beta–blockers. Am. Heart J. 1980; 10: 160–167
   Google Scholar
• Fernandez M. S., Cerbon J. The importance of the hydrophobic interactions of local anesthetics in the displacement of polyvalent cations from artificial lipid membranes. Biochim. Biophys. Acta 1973; 298: 8–14
   PubMed Web of Science ®Google Scholar
• Finer E. G., Flook A. G., Hauser H. The nature and origin of the NMR spectrum of unsonicated and sonicated aqueous egg yolk lecithin dispersions. Biochim. Biophys. Acta 1972; 260: 59–69
   PubMedGoogle Scholar
• Hauser H., Penkett S. A., Chapman D. Nuclear magnetic resonance spectroscopic studies of procaine hydrochloride and tetracaine hydrochloride at lipid–water interfaces. Biochim. Biophys. Acta 1969; 183: 466–475
   PubMedGoogle Scholar
• Hellenbrecht D., Muller K. F., Grobecker H. Prediction of the non–specific car–diodepressant effects of β–adrenoreceptor blocking agents in vitro and in vivo by means of the Hansch analysis. Eur. J. Pharmacol. 1974; 29: 223–235
   Google Scholar
• Herbette L., Katz A. M., Sturtevant J. M. Comparisons of the interaction of propranolol and timolol with model and biological membrane systems. Mol. Pharmacol. 1983; 24: 259–269
   PubMed Web of Science ®Google Scholar
• Hutton W. C., Yeagle P. L., Martin R. B. The interaction lanthanide and calcium salts with phospholipid bilayer vesicles: The validity of the nuclear magnetic resonance method for determination of vesicle bilayer phospholipid surface ratios. Chem. Phys. Lipids 1977; 19: 255–265
   PubMedGoogle Scholar
• Kitamura K., Takahashi T., Hozumi K., Sato T. Proton magnetic resonance study of the interaction of chlorpromazine hydrochloride with lecithin vesicles. Chem. Pharm. Bull. 1978; 26: 256–259
   Google Scholar
• Kondo M., Ogura Y. 1H–NMR Spectroscopic studies of interactions between dimyristoylphosphatidylcholine (DMPC) and europium nitrate in the presence of tetracaine. Jpn. J. Pharmacol. 1985; 39: 21–29
   Google Scholar
• Kumana C. R., Martin G. F. Recent Advances in Clinical Pharmacology, P. Turner. Churchill, EdinburghUK 1978; Vol. 1: 31–54
   Google Scholar
• Lands A. M., Arnold A., McAulif J. P., Laudena F. P., Brown R. G., Jr. Differentiation of receptor systems activated by sympathomimetic amines. Nature 1967; 214: 597–598
   PubMed Web of Science ®Google Scholar
• Lefkowitz F. J. Direct binding studies of adrenergic receptors: Biochemical, physiologic, and clinical implications. Ann. Intern. Med. 1979; 91: 450–458
   PubMed Web of Science ®Google Scholar
• Levine Y. K., Lee A. G., Birdsall N. J.M., Metcalfe J. C., Robinson J. D. The interaction of paramagnetic ions and spin labels with lecithin bilayers. Biochim. Biophys. Acta 1973; 291: 592–607
   Google Scholar
• Levy J. V., Richards V. Inotropic and chronotropic effects of a series of β–adrenergic blocking drugs: Some structure–activity relations. Proc. Soc. Exp. Biol. Med. 1966; 122: 373–379
   PubMed Web of Science ®Google Scholar
• Lullman H., Wehling M. The binding of drugs to different polar lipids in vitro. Biochem. Pharmacol. 1979; 28: 3409–3415
   PubMed Web of Science ®Google Scholar
• Molinoff P. B., Wolfe B. B., Weiland G. A. Quantitative analysis of drug receptor interactions: II. Determination of the properties of receptor subtypes. Life Sci. 1981; 29: 427–443
   PubMed Web of Science ®Google Scholar
• Rogers J. A., Cheng S., Betageri G. V. Association and partitioning of propranolol with model and biological membranes. Biochem. Pharmacol. 1986; 35: 2259–2261
   Google Scholar
• Smith L. H. The chemistry of beta–adrenergic blocking agents relative to cardioselectivity. R. Soc. Med. Int. Congress Symp. Ser. 1980; 19: 93–102
   Google Scholar
• Scales B., McIntosh D. A.D. Effects of propranolol and its optical isomers on the radiocalcium uptake and the adenosine triphosphate of skeletal and cardiac sarcoplasmic reticulum fractions. J. Pharmacol. Exp. Ther. 1968; 160: 261–267
   Google Scholar
• Stark R. E., Gosselin G. J., Donovan J. M., Carey M. C., Roberts M. F. Influence of dilution on the physical state of model bile systems: NMR and quasi–elastic light scattering investigations. Biochemistry 1985; 24: 5599–5605
   PubMed Web of Science ®Google Scholar
• Surewicz K. W., Leyko W. Interaction of propranolol with model phospholipid membranes. Biochim. Biophys. Acta 1981; 643: 387–397
   PubMed Web of Science ®Google Scholar